| Letters
in Drug Design & Discovery
ISSN: 1570-1808

Letters in Drug Design &
Discovery
Volume 4, Number 1, January 2007

| Azapteridine Inhibitors of Hepatitis
C Virus RNA-Dependent RNA Polymerase Pp. 1-8 |
T. Middleton,
H.B. Lim, D. Montgomery, T. Rockway, D. Liu, L.
Klein, W. Qin, J.E. Harlan, W.M. Kati & A.
Molla
[Full Text Article]

Toxoflavin analogs have antibacterial, antifungal
and antitumor effects, and were potent inhibitors
of Hepatitis C virus RNA-dependent RNA polymerase.
Inhibition appeared to be via a redox-related
mechanism, which may explain the toxicity of this
class of compounds. |
|

[Back to top]
| Sodium Proton Exchanger Inhibitor
in Ischemia/Reperfusion Injury in the Heart Surgery: Controversy
in Clinical Application Pp. 9-14 |
Y. Shimada
& F. Yamamoto
[Full Text Article]
The Na +/H + exchange inhibitor
shown to protect the heart against ischemia/reperfusion
injury in experimental studies, but only limited
protection in prospective and randomized clinical
studies. We review the studies on Na +/H +
exchanger inhibitors and discuss the reasons for
the inconsistencies in clinical studies. |
|

[Back to top]
| Structure-Based Virtual Screening:
Identification of Novel CB2 Receptor Ligands
Pp. 15-19 |
T. Tuccinardi,
Maria G. Cascio, V. Di Marzo, C. Manera, G. Ortore,
G. Saccomanni & A. Martinelli
[Full Text Article]
A structure-based virtual screening, using
AUTODOCK and a previously published CB2 receptor
model, allowed to find three compound showing
K i values of 7.8-8.0 μM
from the Maybridge database. |
|
|

[Back to top]
| Inhibitors of the Chemokine Receptor
CXCR4: Chemotherapy of AIDS, Metastatic Cancer, Leukemia
and Rheumatoid Arthritis Pp. 20-26 |
H. Tsutsumi,
H. Tamamura & N. Fujii
[Full Text Article]

CXCR4 has played important roles in several
intractable diseases, including HIV infection,
cancer cell metastasis, leukemia cell progression
and rheumatoid arthritis. Thus, CXCR4 is thought
to be an important therapeutic target in all of
these diseases, and a lot of CXCR4 antagonists
have been developed all over the world. |
|

[Back to top]
| Design, Synthesis and Evaluation
of Peroxisome Proliferator-Activated Receptor α/γ
Dual Agonists for the Treatment of Type 2 Diabetes
Pp. 27-32 |
S.K. Das,
C. Abbineni, K.V.L.N. Rao, J. Iqbal, R.K. Babu
& R. Chakrabarti
[Full
Text Article]

The design and synthesis of the dual PPAR α/ γ
agonists with three different heterocycles are
described. 5cb possesses a potent dual PPAR α/ γ
agonist property. It significantly reversed diabetic
hyperglycemia while improving overall lipid homeostasis
in preclinical animal models. |
|
|

[Back to top]
| Relation Between Scaffold Size
and Membrane Bound Enzyme Caused Degradation of Two Novel
Cystine Knot Microproteins Pp. 33-36 |
M. Werle,
H. Kolmar & A. Bernkop-Schnürch
[Full Text Article]
Cystine knot microproteins are promising novel
scaffolds for the oral delivery of pharmacophoric
sequences. These scaffolds should be stable towards
membrane bound enzymes of the intestinal mucosa.
The hypothesis that scaffolds with 37 amino acids
(SE-ET-TP-020) are more susceptible towards MBE
caused degradation in comparison to scaffolds
with about 30 amino acids (SE-MC-TR-020) could
be supported. |
|

[Back to top]
| Synthesis and Preliminary Antitumor
Activity of Distamycin Nitrogen Mustards Pp.
37-39 |
Y. Wang, Z. Yang, S.C. Wright
& J.W. Larrick
[Full Text Article]

Synthesis of distamycin nitrogen mustards is reported. |
|

[Back to top]
| Designing Promiscuous Drugs? Look
at What Nature Made! Pp. 40-43 |
A.M. Fialho,
T.K.D. Gupta & A.M. Chakrabarty
[Full Text Article]

Azurin from Pseudomonas aeruginosa: a
well designed drug candidate. The drug industry
primarily has relied on drugs that target a single
gene or enzyme in a pathway involved in disease
progression with the idea that such a drug will
have minimum side effects and maximal efficacy.
Recent observations, however, indicate that a
drug that has multiple targets, thus exhibiting
promiscuity, is often more efficacious. Recent
studies with pathogenic bacteria demonstrate that
such bacteria produce redox proteins that appear
to act as weapons against various invaders of
human body that cause diseases such as cancers,
malaria or AIDS. The potential of finding such
promiscuous bacterial proteins may lead in the
future to an antibiotic-like industry targeted
towards non-prokaryotic agents of human diseases. |
|
[Back to top]
| Sirtuins, Nicotinamide and Aging:
A Critical Review Pp. 44-48 |
J.D. Adams
Jr. & L.K. Klaidman
[Full Text Article]
Sirtuins are enzymes that deacetylate proteins
at the expense of NAD. The nuclear forms of sirtuins
have generated an enormous amount of interest
due to their putative role in lifespan extension. |
|
[Back to top]
| Synthesis and Antimalarial Activity
of (E) 2-(2´-Chloro-3´-Quinolinylmethylidene)-5,7-Dimethoxyindanones
Pp. 49-54 |
J.E.Charris,
G.M. Lobo, J.R. Camacho, R.E. Ferrer, A.R. Barazarte,
J.N. Domínguez, N. Gamboa, J.R. Rodrigues
& J.E. Angel
[Full Text Article]
A series of ( E) 2-quinolinylmethyliden-5,7-dimethoxyindanones
were prepared by a base catalyzed Claisen-Schmidt
condensation of 5,7 dimethoxy-1-indanone with
the appropriate 2-chloro-3-formylquinoline derivatives.
Compounds were evaluated in vitro for
their ability to inhibit β
hematin formation and hemoglobin hydrolysis and
in vivo for their efficacy in rodent
Plasmodium berghei. Compounds emerging
from the in vitro studies together with
a good survival in a malaria murine model suggest
that quinolinylmethyliden-5,7-dimetoxyindanones
exert their antimalarial activity via
inhibition of the hemoglobinolytic proteases. |
|
[Back to top]
| Effects of Nitric Oxide Donors
on the Biological Activity of Human Neutrophils In
Vitro. Review Own Studies Pp. 55-66 |
M. Klink
& Z. Sulowska
[Full Text Article]
The effect of pharmacologically active compounds
that liberate nitric oxide on human neutrophils
activities in vitro is described. SNP,
SIN-1, DEA/NO decrease the pro-inflammatory action
of activated neutrophils, without reducing their
ability to kill bacteria. |
|
[Back to top]
| Amphibian Secretions for Drug
Discovery Studies: A Search for New Antiparasitic and
Antifungal Compounds Pp. 67-73 |
A.G. Tempone,
M.S.C. Melhem, F.O. Prado, G. Motoie, R.M. Hiramoto,
M.M. Antoniazzi, C.F.B. Haddad & C. Jared
[Full Text Article]
The antiparasitic and antifungal activities of
nine amphibian skin secretions were studied in
different in vitro models. Seven secretions
presented a considerable antiprotozoan activity
and one showed promising results against Candida
sp. These results can be the basis for the
development of new drugs, especially for neglected
parasitic diseases. |
|
[Back to top]
| Generation of a Droplet Inside
a Microbubble with the Aid of an Ultrasound Contrast Agent:
First Result Pp. 74-77 |
M. Postema,
F.J. ten Cate, G. Schmitz, N. de Jong & A.
van Wamel
[Full Text Article]
Antibubbles consist of a liquid core encapsulated
by a gas shell. They might be suitable carriers
for ultrasound-assisted drug delivery. The creation
of an antibubble with the aid of ultrasound has
been demonstrated with high-speed photography. |
|
[Back to top]
| Production of Tablet-Like Solid
Bodies Without Pressure by Sol-Gel Processes Pp.
78-81 |
N. Pachulski
& J. Ulrich
[Full Text Article]
Tablet-like bodies are produced from a water based
suspension by a sol-gel, a freeze-casting and
a drying process without the standard compression.
The dissolution influencing pores in these bodies
correspond to the negative images of the former
ice crystals and therefore can be regulated by
the process conditions. |
|
[Back to top]
|